USPTO serial 87348269
A
Reviewed by CopyMark Law Group
Status 603
- Filing date
- Status date
- Registration date
- —
- Examiner
- WELLS, KELLEY L
- Law office
- TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with A?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jacqueline M. Lesser
JACQUELINE M LESSER BAKER & HOSTETLER LLP2929 ARCH STREET CIRA CENTRE12TH FLOORPHILADELPHIA, PA 19104-2891Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for the prevention and treatment of cancer; Dermatological pharmaceutical products; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of joint disease; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Intravenous bags, syringes, and vials sold filled with injectable pharmaceutical preparations, namely, oncologic products and ancillary products, chemotherapy agents, anti-emitics, and anti-infectives; Anticholinergics; Anticholinesterases; Anti-hypotensives; Biological preparations for the treatment of cancer; Anesthetics for surgical and non-surgical use; Antibiotics; Antiemetics; Analgesics; Sedatives; Dietary supplements; Vaccines; Blood for medical purposes; all of the foregoing featuring differentiated packaging for the purpose of reducing user errors and promoting correct medication selection | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 11, 2018 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Oct 10, 2018 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| Oct 10, 2018 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Oct 10, 2018 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Jul 12, 2018 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jul 12, 2018 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jul 12, 2018 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Jun 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 28, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 28, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jun 13, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 13, 2018 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jun 13, 2018 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jun 13, 2018 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Dec 14, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 14, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 14, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 1, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 30, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 20, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 3, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 2, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 28, 2017 | NWAP | NEW APPLICATION ENTERED | — |